96 related articles for article (PubMed ID: 3536076)
1. Differential turnover of the subunits of ribonucleotide reductase in synchronized leukemia L1210 cells.
Rubin EH; Cory JG
Cancer Res; 1986 Dec; 46(12 Pt 1):6165-8. PubMed ID: 3536076
[TBL] [Abstract][Full Text] [Related]
2. Changes in messenger RNA levels for the subunits of ribonucleotide reductase during the cell cycle of leukemia L1210 cells.
Thompson DP; Carter GL; Cory JG
Cancer Commun; 1989; 1(4):253-60. PubMed ID: 2700914
[TBL] [Abstract][Full Text] [Related]
3. In vivo growth of mouse leukemia L1210 cells with metabolic alterations in the subunits of ribonucleotide reductase.
Somerville L; Cory AH; Cory JG
In Vivo; 2002; 16(3):175-7. PubMed ID: 12182112
[TBL] [Abstract][Full Text] [Related]
4. Characterization of mouse leukemia L1210 cells resistant to the ribonucleotide reductase inhibitor 4-methyl-5-amino-1-formylisoquinoline thiosemicarbazone.
Cory AH; Sato A; Thompson DP; Cory JG
Oncol Res; 1996; 8(10-11):449-56. PubMed ID: 9114437
[TBL] [Abstract][Full Text] [Related]
5. Cross-resistance patterns in hydroxyurea-resistant leukemia L1210 cells.
Carter GL; Cory JG
Cancer Res; 1988 Oct; 48(20):5796-9. PubMed ID: 2844392
[TBL] [Abstract][Full Text] [Related]
6. Cell cycle regulation of ribonucleoside diphosphate reductase activity in permeable mouse L cells and in extracts.
Kucera R; Brown CL; Paulus H
J Cell Physiol; 1983 Nov; 117(2):158-68. PubMed ID: 6355126
[TBL] [Abstract][Full Text] [Related]
7. Effects of N-hydroxy-N'-aminoguanidine derivatives on ribonucleotide reductase activity, nucleic acid synthesis, clonogenicity, and cell cycle of L1210 cells.
Weckbecker G; Weckbecker A; Lien EJ; Cory JG
Cancer Res; 1987 Feb; 47(4):975-8. PubMed ID: 2433036
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of ribonucleotide reductase by gallium in murine leukemic L1210 cells.
Chitambar CR; Narasimhan J; Guy J; Sem DS; O'Brien WJ
Cancer Res; 1991 Nov; 51(22):6199-201. PubMed ID: 1933878
[TBL] [Abstract][Full Text] [Related]
9. Factors affecting the mRNA levels for the non-heme iron and effector-binding subunits of ribonucleotide reductase.
Carter GL; Cory JG
Adv Enzyme Regul; 1992; 32():227-40. PubMed ID: 1496919
[TBL] [Abstract][Full Text] [Related]
10. Substituted 2-acylpyridine-alpha-(N)-hetarylhydrazones as inhibitors of ribonucleotide reductase activity and L1210 cell growth.
Cory JG; Downes DL; Cory AH; Schaper KJ; Seydel JK
Anticancer Res; 1994; 14(3A):875-9. PubMed ID: 8074487
[TBL] [Abstract][Full Text] [Related]
11. Ribonucleotide reductase M1 subunit in cellular proliferation, quiescence, and differentiation.
Mann GJ; Musgrove EA; Fox RM; Thelander L
Cancer Res; 1988 Sep; 48(18):5151-6. PubMed ID: 3044582
[TBL] [Abstract][Full Text] [Related]
12. Leukemia L1210 cell lines resistant to ribonucleotide reductase inhibitors.
Cory JG; Carter GL
Cancer Res; 1988 Feb; 48(4):839-43. PubMed ID: 3276399
[TBL] [Abstract][Full Text] [Related]
13. Protein properties of the subunits of ribonucleotide reductase and the specificity of the allosteric site(s).
Cory JG; Sato A; Brown NC
Adv Enzyme Regul; 1986; 25():3-19. PubMed ID: 3544706
[TBL] [Abstract][Full Text] [Related]
14. Comparison of the actions of 9-beta-D-arabinofuranosyl-2-fluoroadenine and 9-beta-D-arabinofuranosyladenine on target enzymes from mouse tumor cells.
White EL; Shaddix SC; Brockman RW; Bennett LL
Cancer Res; 1982 Jun; 42(6):2260-4. PubMed ID: 7042080
[TBL] [Abstract][Full Text] [Related]
15. Differential sensitivities of the subunits of mammalian ribonucleotide reductase to proteases, sulfhydryl reagents, and heat.
Sato A; Cory JG
Arch Biochem Biophys; 1986 Feb; 244(2):572-9. PubMed ID: 3511848
[TBL] [Abstract][Full Text] [Related]
16. Phenotypic changes in mouse leukemia L1210 cells with alterations in the effector-binding subunit of ribonucleotide reductase.
Cory JG; Somerville L; He AW; Cory AH
Adv Enzyme Regul; 2000; 40():3-15. PubMed ID: 10828342
[No Abstract] [Full Text] [Related]
17. The utility of combinations of drugs directed at specific sites of the same target enzyme--ribonucleotide reductase as the model.
Cory JG; Sato A; Carter GL; Bacon PE; Montgomery JA; Brown NC
Adv Enzyme Regul; 1985; 23():181-92. PubMed ID: 3907303
[TBL] [Abstract][Full Text] [Related]
18. Half-lives of ornithine decarboxylase and S-adenosylmethionine decarboxylase activities during the cell cycle of Chinese hamster ovary cells.
Berntsson PS; Alm K; Oredsson SM
Biochem Biophys Res Commun; 1999 Sep; 263(1):13-6. PubMed ID: 10486245
[TBL] [Abstract][Full Text] [Related]
19. Characterization of L1210 cell growth inhibition by the bacterial iron chelators parabactin and compound II.
Cavanaugh PF; Porter CW; Tukalo D; Frankfurt OS; Pavelic ZP; Bergeron RJ
Cancer Res; 1985 Oct; 45(10):4754-9. PubMed ID: 4027962
[TBL] [Abstract][Full Text] [Related]
20. Alterations in the cyclic AMP signal transduction pathway regulating ribonucleotide reductase gene expression in malignant H-ras transformed cell lines.
Hurta RA; Wright JA
J Cell Physiol; 1994 Jan; 158(1):187-97. PubMed ID: 7505277
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
